Frazier Life Sciences Management’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-17,025
Closed -$29.7K 53
2023
Q1
$29.7K Hold
17,025
﹤0.01% 49
2022
Q4
$32.2K Hold
17,025
﹤0.01% 44
2022
Q3
$35K Sell
17,025
-1
-0% -$2 ﹤0.01% 43
2022
Q2
$77K Hold
17,026
0.01% 41
2022
Q1
$179K Buy
+17,026
New +$179K 0.02% 42